BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9211158)

  • 1. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment.
    Jensen ET; Giwercman B; Ojeniyi B; Bangsborg JM; Hansen A; Koch C; Fiehn NE; Høiby N
    J Hosp Infect; 1997 Jun; 36(2):117-22. PubMed ID: 9211158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in the Danish Cystic Fibrosis Centre.
    Zembrzuska-Sadkowska E; Sneum M; Ojeniyi B; Heiden L; Høiby N
    J Hosp Infect; 1995 Jan; 29(1):1-7. PubMed ID: 7738336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotyping of Pseudomonas aeruginosa sputum and stool isolates from cystic fibrosis patients: evidence for intestinal colonization and spreading into toilets.
    Döring G; Bareth H; Gairing A; Wolz C; Botzenhart K
    Epidemiol Infect; 1989 Dec; 103(3):555-64. PubMed ID: 2514111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of contamination of the dentist and dental surgery environment with Burkholderia (Pseudomonas) cepacia during treatment of children with cystic fibrosis.
    Pankhurst CL; Harrison VE; Philpott-Howard J
    Int J Paediatr Dent; 1995 Dec; 5(4):243-7. PubMed ID: 8957838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment.
    Pitchford KC; Corey M; Highsmith AK; Perlman R; Bannatyne R; Gold R; Levison H; Ford-Jones EL
    J Pediatr; 1987 Aug; 111(2):212-6. PubMed ID: 3612391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case-Control Study.
    Rivas Caldas R; Le Gall F; Revert K; Rault G; Virmaux M; Gouriou S; Héry-Arnaud G; Barbier G; Boisramé S
    J Clin Microbiol; 2015 Jun; 53(6):1898-907. PubMed ID: 25854483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: A case-control analysis.
    Goeminne PC; Nawrot TS; De Boeck K; Nemery B; Dupont LJ
    J Cyst Fibros; 2015 Nov; 14(6):741-7. PubMed ID: 25940953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre - results of a 10-year prospective study.
    Wiehlmann L; Cramer N; Ulrich J; Hedtfeld S; Weissbrodt H; Tümmler B
    Int J Med Microbiol; 2012 Mar; 302(2):69-77. PubMed ID: 22196973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa.
    Pages-Monteiro L; Marti R; Commun C; Alliot N; Bardel C; Meugnier H; Perouse-de-Montclos M; Reix P; Durieu I; Durupt S; Vandenesch F; Freney J; Cournoyer B; Doleans-Jordheim A
    PLoS One; 2017; 12(3):e0173022. PubMed ID: 28282386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative hygienic surveillance of contamination with pseudomonads in a cystic fibrosis ward over a 4-year period.
    Bosshammer J; Fiedler B; Gudowius P; von der Hardt H; Römling U; Tümmler B
    J Hosp Infect; 1995 Dec; 31(4):261-74. PubMed ID: 8926376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of Pseudomonas aeruginosa in waters: implications for patients with cystic fibrosis (CF).
    Caskey S; Stirling J; Moore JE; Rendall JC
    Lett Appl Microbiol; 2018 Jun; 66(6):537-541. PubMed ID: 29537700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.
    Aaron SD; Vandemheen KL; Ramotar K; Giesbrecht-Lewis T; Tullis E; Freitag A; Paterson N; Jackson M; Lougheed MD; Dowson C; Kumar V; Ferris W; Chan F; Doucette S; Fergusson D
    JAMA; 2010 Nov; 304(19):2145-53. PubMed ID: 21081727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.
    Fernández-Barat L; Ciofu O; Kragh KN; Pressler T; Johansen U; Motos A; Torres A; Hoiby N
    J Cyst Fibros; 2017 Mar; 16(2):222-229. PubMed ID: 27651273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
    Sanderson K; Wescombe L; Kirov SM; Champion A; Reid DW
    Eur Respir J; 2008 Aug; 32(2):329-33. PubMed ID: 18480103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.
    Jelsbak L; Johansen HK; Frost AL; Thøgersen R; Thomsen LE; Ciofu O; Yang L; Haagensen JA; Høiby N; Molin S
    Infect Immun; 2007 May; 75(5):2214-24. PubMed ID: 17261614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Petersen US; Høiby N
    APMIS; 1993 Feb; 101(2):168-75. PubMed ID: 8098219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-infections with Pseudomonas aeruginosa in patients with cystic fibrosis attending the Warsaw Centre.
    Milczewska J; Wołkowicz T; Zacharczuk K; Kwiatkowska M
    Dev Period Med; 2015; 19(1):60-5. PubMed ID: 26003071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.